Stryker Corp STRYKER ORD SHS
Stryker Corp STRYKER ORD SHS/ US8636671013 /
0R2S
|
5/24/2024 3:30:02 PM
|
Chg.
-
|
Volume |
Bid6:00:06 AM |
Ask6:00:06 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
330.69USD
|
-
|
360
Turnover: 6,283.11 |
-Bid Size: - |
-Ask Size: - |
148.44 bill.USD |
0.78% |
46.69 |
Business description
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Management board & Supervisory board
| CEO |
| Kevin A. Lobo |
| Management board |
| Glenn Boehnlein, Yin Becker, Katy Fink, Rob Fletcher, Viju Menon, Andy Pierce, Spencer Stiles |
| Supervisory board |
| Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Srikant M. Datar, Giovanni Caforio, Lisa M. Skeete Tatum, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy |
Company data
| Name: |
Stryker Corporation |
| Address: |
2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA |
| Phone: |
+1-269-385-2600 |
| Fax: |
+1-269-385-1062 |
| E-mail: |
-
|
| Internet: |
www.stryker.com |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
64.10% |
| IPO date: |
1/1/1979 |
